cardiomyopathy
cardiomyopathy
Explore linked clinical trials. Standard reference: MONDO:0004994393 results ยท Page 1 of 16
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ATI-105 in Healthy Adults | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Friedreich ataxia, Mitochondrial Dysfunction, Nutritional and Metabolic Diseases, Spinocerebellar Degenerations, brain disorder, cardiomyopathy, cardiovascular disorder, central nervous system disorder, cerebellar disorder, heart disorder, hereditary disease, inborn mitochondrial metabolism disorder, inherited neurodegenerative disorder, metabolic disease, nervous system disorder, neurodegenerative disease, neuromuscular disease, spinal cord disorder | Not yet recruiting | Phase 1 | 2026-10-09 | NCT07869654 | |
| NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Multi-Center Prospective Study Using Improvised Off-Label Devices | Ventricular Outflow Obstruction, Ventricular Outflow Obstruction, Left, aortic valve disorder, aortic valve stenosis, cardiomyopathy, cardiovascular disorder, heart disorder, heart valve disorder, hypertrophic cardiomyopathy, subvalvular aortic stenosis | Not yet recruiting | Not applicable | 2026-10-09 | NCT07806149 | |
| Human Experimental Models of Pain (HEMP) | Acute Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, aortic valve disorder, aortic valve stenosis, cardiomyopathy, cardiovascular disorder, heart disorder, heart valve disorder, hypertrophic cardiomyopathy, subvalvular aortic stenosis | Not yet recruiting | Not applicable | 2026-10-09 | NCT07549490 | |
| DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting | Nutritional and Metabolic Diseases, amyloidosis, cardiomyopathy, cardiovascular disorder, heart disorder, metabolic disease, proteostasis deficiencies | Recruiting | Not stated | 2026-10-09 | NCT07358078 | |
| Hypertrophic Cardiomyopathy Registry, Biobank and Imaging Data Repository | Cardiomyopathy, Hypertrophic Obstructive, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Death, Death, Sudden, Death, Sudden, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, aortic valve disorder, aortic valve stenosis, cardiac arrest, cardiomyopathy, cardiovascular disorder, familial hypertrophic cardiomyopathy, heart disorder, heart valve disorder, hereditary disease, hypertrophic cardiomyopathy, subvalvular aortic stenosis | Recruiting | Not stated | 2026-10-09 | NCT05100420 | |
| Coronary Sinus Reducer Objective Impact on SymptoMs, Ischaemia and miCrovascular Resistance in Non-obstructive Hypertrophic CardioMyopathy | Angina Pectoris, Arterial Occlusive Diseases, Chest Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, aortic valve disorder, aortic valve stenosis, arteriosclerosis disorder, cardiomyopathy, cardiovascular disorder, coronary artery disorder, heart disorder, heart valve disorder, hypertrophic cardiomyopathy, myocardial ischemia, subvalvular aortic stenosis, vascular disorder | Not yet recruiting | Not applicable | 2026-10-08 | NCT07865364 | |
| A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting | cardiomyopathy, cardiovascular disorder, familial amyloid neuropathy, heart disorder, heart failure | Recruiting | Not stated | 2026-10-08 | NCT07235462 | |
| A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease | Cardiomegaly, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Danon disease, Hypertrophy, Hypertrophy, Left Ventricular, Neurobehavioral Manifestations, Neurologic Manifestations, Nutritional and Metabolic Diseases, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, X-linked disease, aortic valve disorder, aortic valve stenosis, cardiomyopathy, cardiovascular disorder, disorder of glycogen metabolism, heart disorder, heart valve disorder, hereditary disease, hypertrophic cardiomyopathy, inborn carbohydrate metabolic disorder, inborn errors of metabolism, intellectual disability, lysosomal storage disease, metabolic disease, nervous system disorder, subvalvular aortic stenosis | Recruiting | Phase 2 | 2026-10-06 | NCT06092034 | |
| Nutritional Assessment in Children With Cardiomyopathy | Nutritional and Metabolic Diseases, cardiomyopathy, cardiovascular disorder, heart disorder, nutritional deficiency disease, nutritional disorder | Not yet recruiting | Not stated | 2026-10-05 | NCT07858474 | |
| Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging | Angina Pectoris, Arterial Occlusive Diseases, Cardiovascular Abnormalities, Chest Pain, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiomyopathy, cardiovascular disorder, congenital heart disease, coronary artery disorder, heart disorder, heart failure, heart valve disorder, myocardial ischemia, vascular disorder | Recruiting | Not stated | 2026-10-05 | NCT03581318 | |
| BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic Cardiomyopathy | Cardiomyopathy, Hypertrophic Obstructive, aortic valve disorder, aortic valve stenosis, cardiomyopathy, cardiovascular disorder, heart disorder, heart valve disorder, hypertrophic cardiomyopathy, subvalvular aortic stenosis | Recruiting | Phase 3 | 2026-10-02 | NCT07755904 | |
| Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System | Arterial Occlusive Diseases, Body Weight, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA repair disease, Li-Fraumeni syndrome, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiomyopathy, cardiovascular disorder, heart disorder, hereditary disease, hereditary neoplastic syndrome, inflammatory disease, metabolic disease, neoplasm, nutritional disorder, obesity disorder, overnutrition, vascular disorder | Recruiting | Not stated | 2026-10-02 | NCT01143454 | |
| Patient Selection and Long-Term Outcomes of Pace & Ablate Strategy in Atrial Fibrillation | Arrhythmias, Cardiac, Cardiomyopathies, Secondary, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiomyopathy, cardiovascular disorder, heart disorder, heart failure | Recruiting | Not stated | 2026-10-01 | NCT07852221 | |
| A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy | Cardiomegaly, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dilatation, Pathologic, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, cardiomyopathy, cardiovascular disorder, dilated cardiomyopathy, heart disorder, heart failure, hereditary disease, laminopathy | Recruiting | Phase 1 | 2026-10-01 | NCT07137338 | |
| A Study to Assess the Treatment of Obstructive Hypertrophic Cardiomyopathy (oHCM) With Mavacamten in the US | aortic valve disorder, aortic valve stenosis, cardiomyopathy, cardiovascular disorder, heart disorder, heart valve disorder, hypertrophic cardiomyopathy, subvalvular aortic stenosis | Active, not recruiting | Not stated | 2026-09-30 | NCT07107373 | |
| COLLIGO-HCM: A Multinational Observational Study of the Real-World Effectiveness of Mavacamten Among Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) | aortic valve disorder, aortic valve stenosis, cardiomyopathy, cardiovascular disorder, heart disorder, heart valve disorder, hypertrophic cardiomyopathy, subvalvular aortic stenosis | Active, not recruiting | Not stated | 2026-09-30 | NCT06372457 | |
| Soluble TREM-1 in Diabetes-Associated Cardiovascular Complications | Arrhythmias, Cardiac, Arterial Occlusive Diseases, Diabetes Complications, Diabetic Cardiomyopathies, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, cardiomyopathy, cardiovascular disorder, coronary artery disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, heart disorder, heart failure, metabolic disease, myocardial ischemia, type 2 diabetes mellitus, vascular disorder | Not yet recruiting | Not stated | 2026-09-29 | NCT07847112 | |
| Aficamten and Patient-Reported Outcomes in Real-World nHCM | aortic valve disorder, aortic valve stenosis, cardiomyopathy, cardiovascular disorder, heart disorder, heart valve disorder, hypertrophic cardiomyopathy, subvalvular aortic stenosis | Not yet recruiting | Not stated | 2026-09-29 | NCT07846176 | |
| Evaluation of Mavacamten-Based Practice in Chinese Adults With Obstructive Hypertrophic Cardiomyopathy | aortic valve disorder, aortic valve stenosis, cardiomyopathy, cardiovascular disorder, heart disorder, heart valve disorder, hypertrophic cardiomyopathy, subvalvular aortic stenosis | Not yet recruiting | Not stated | 2026-09-29 | NCT07846059 | |
| NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study | Diabetes Complications, Diabetic Cardiomyopathies, Nutritional and Metabolic Diseases, cardiomyopathy, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, heart disorder, heart failure, metabolic disease, type 2 diabetes mellitus | Recruiting | Not applicable | 2026-09-29 | NCT06593327 | |
| Spectroscopic Assessment of Myocardial Oxygenation Changes in Pediatric Heart Surgery | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Myocardial Reperfusion Injury, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, cardiomyopathy, cardiovascular disorder, congenital heart disease, heart disorder, ischemia reperfusion injury, myocardial ischemia, vascular disorder | Recruiting | Not stated | 2026-09-28 | NCT07785141 | |
| A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter | Arrhythmias, Cardiac, Cardiac Complexes, Premature, Cardiac Conduction System Disease, Idiopathic Ventricular Tachycardia, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tachycardia, Ventricular Premature Complexes, atrial fibrillation, cardiomyopathy, cardiovascular disorder, heart disorder, paroxysmal atrial fibrillation, persistent atrial fibrillation, ventricular tachycardia | Recruiting | Not applicable | 2026-09-28 | NCT07116525 | |
| Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia | Cardiac Hypertrophy, Cardiomegaly, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyskinesias, Friedreich ataxia, Hypertrophy, Neurologic Manifestations, Nutritional and Metabolic Diseases, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Spinocerebellar Degenerations, atactic disorder, non-human animal, brain disorder, cardiomyopathy, cardiovascular disorder, central nervous system disorder, cerebellar disorder, heart disorder, hereditary disease, inborn mitochondrial metabolism disorder, inherited neurodegenerative disorder, metabolic disease, nervous system disorder, neurodegenerative disease, spinal cord disorder | Recruiting | Phase 1 | 2026-09-28 | NCT05302271 | |
| Individualized Exercise Training in Hypertrophic Cardiomyopathy | aortic valve disorder, aortic valve stenosis, cardiomyopathy, cardiovascular disorder, heart disorder, heart valve disorder, hypertrophic cardiomyopathy, subvalvular aortic stenosis | Not yet recruiting | Not applicable | 2026-09-23 | NCT07835854 | |
| Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy. | Cardiomyopathies, Secondary, cardiomyopathy, cardiovascular disorder, heart disorder, heart failure, myocarditis | Active, not recruiting | Phase 4 | 2026-09-22 | NCT04654988 |